Friday, February 17, 2023

AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer

AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer BTC is a group of rare and aggressive gastrointestinal (GI) cancers that form in the cells of the bile ducts (cholangiocarcinoma), gallbladder or ampulla of Vater (where the bile duct and pancreatic duct connect to the small intestine).

from Moneycontrol Business News https://ift.tt/Z9nD1Ma
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...